About Us
Disease Focus
Dry Eye Disease
Non-infectious Anterior Uveitis
Allergic Conjunctivitis
Chronic Pain
Ocular Pain
Technology
R&D Pipeline
Investor Relations
Share Information
Shareholder Services
Corporate Governance
Corporate Information
Corporate Documents
Corporate Directory
News
Contact Us
Latest News
20 May 2019
Result of General Meeting, Admission of Subscription Shares and Total Voting Rights
26 April 2019
Subscription of 36,363,636 new Ordinary Shares at a price of 1.1 pence per share to raise gross proceeds of £400,000 Proposed Approval of Waiver of the obligations under Rule 9 of the Takeover Code and Notice of General Meeting
14 March 2019
OKYO releases preclinical data on OKYO-0101 at the 14th Congress on Ocular Pharmacology and Therapeutics, 2019 demonstrating its potential to treat dry eye.
07 March 2019
Presentation of Preclinical Data Demonstrating Potential of OKYO-0101 for Dry Eye Treatment
23 January 2019
OKYO Pharma Corporate Update
30 November 2018
Interim results for the six months to 30 September 2018
Page 2 of 3
Previous
Next